# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001610618-24-000089
Filing Date
2024-06-03
Accepted
2024-06-03 16:58:44
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-06-03

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | cdtx10-k2023x12x31_ars.pdf | ARS | 10581757
| Complete submission text file | 0001610618-24-000089.txt |  | 14578057

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36912 | Film No.: 241014407
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)